To include your compound in the COVID-19 Resource Center, submit it here.

Bill seeks to introduce ‘pull’ incentive for antibiotics

Two members of the House Energy and Commerce Committee introduced legislation that would create a new “pull” incentive pathway for priority antibiotics, providing manufacturers a transferable award that could be worth $1 billion or more. The bill, the Re-Valuing Anti-Microbial Products (REVAMP) Act of 2018, aims

Read the full 468 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE